The largest database of trusted experimental protocols

Cosmosil 5c18 ms 2 column

Manufactured by Nacalai Tesque
Sourced in Japan, United States

The Cosmosil 5C18-MS-II column is a type of liquid chromatography column used for the separation and analysis of various compounds. It features a silica-based stationary phase with C18 alkyl chains, which is commonly used for reversed-phase chromatographic separations. The column dimensions and particle size may vary depending on the specific application.

Automatically generated - may contain errors

44 protocols using cosmosil 5c18 ms 2 column

1

LC-TOF/MS Analysis of Ether Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ether concentrate was 10-fold diluted with methanol prior to LC-TOF/MS analysis. LC separation was performed using an Agilent 1200 series HPLC (Agilent Technologies) on a Cosmosil 5C18-MS-II column (2.0 mm × 150 mm, Nacalai Tesque) under a linear gradient of 0.1% formic acid (FA) to 100% methanol containing 0.1% FA over 30 min at 0.2 mL/min and 40 °C. MS analysis in a single negative electrospray-ionization (ESI) mode was performed using a micrOTOF-II mass spectrometer (Bruker Daltonics, Bremen, Germany). ESI-MS conditions were as follows: drying N2 gas flow rate, 8.0 L/min; drying temperature, 200 °C; nebulizer gas pressure, 1.6 bar; capillary voltage, 3800 V. At the beginning of each run, m/z was calibrated by 10 mM sodium formate. Identification of targets was achieved by matching of mass unit and retention time on LC column with standards. Data acquisition and analysis were carried out using a Bruker Data Analysis 3.2 software.
+ Open protocol
+ Expand
2

Quantitative HPLC Analysis of Carbamazepine

Check if the same lab product or an alternative is used in the 5 most similar protocols
CBZ concentration in the EN or plasma samples was determined by high-performance liquid chromatography (HPLC). One microgram of the internal standard (flunitrazepam) and 50 μL of acetonitrile were added to 50 µL of the samples. The samples were vortexed for 30 s and centrifuged at 11,200 ×g for 20 min at 4 °C. Thereafter, 50 µL of the supernatant was transferred to a clean tube, and 20 µL of the supernatant was injected into the HPLC system.
The HPLC system used was a Shimadzu VP-series consisting of an LC-20AD pump, DGU-20A deaeration unit, CTO-20Avp column oven, SPD-20ADvp UV detector, and SIL-20ADvp auto-injector, controlled by an SCL-20 Avp controller (Shimadzu Co., Kyoto, Japan). Separations were performed on a Cosmosil® 5C18-MS-II column (4.6 mm I.D. × 150 mm; Nacalai Tesque, Inc., Kyoto, Japan), preceded by a run through the Cosmosil® 5C18-MS-II guard column (4.6 mm I.D. × 10 mm). The mobile phase (15 mM phosphate buffer:acetonitrile (25:55 (v/v)) was flowed at 0.8 mL/min. The column temperature was maintained at 40 °C, and eluting peaks were monitored by UV absorbance at 215 nm.
+ Open protocol
+ Expand
3

HPLC-UV Analysis of Pharmaceutical Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPLC-UV analysis was performed using a Waters HPLC System (Waters Corporation), including a 600 quaternary pump, a Sugai U-620 column temperature controller, a 717 plus autosampler and a 996-photodiode array detector. The analytical conditions were set as follows: gradient elution by the mixture of mobile phases A (0.085% phosphoric acid) and B (acetonitrile) at 0–10 min with a ratio of 85–90% A and 10–15% B; 10–20 min with a ratio of 80–85% A and 15–20% B; 20–30 min with a ratio of 60–80% A and 20–40% B; 30–55 min with a ratio of 35–60% A and 40–65% B; 55–65 min with a ratio of 0–35% A and 65–100% B; and 65–80 min with the ratio of 0–90% A and 10–100% B. The flow rate was kept constant at 1.0 ml/min. The column temperature was controlled at 35°C, the post time was 15 min and the injection volume was 20 µl. The UV wavelength for full detection was set at 200–600 nm. The analytical column was a Cosmosil 5C18-MS-II column (particle size, 5 µm; column size, 4.6 mm internal diameter) ×250 mm; Nacalai Tesque, Inc.) and a Lichrospher RP-18 end-capped column (particle size, 5 µm; column size, 4.0 mm internal diameter ×10 mm; Merck KGaA) was used as a guard column.
+ Open protocol
+ Expand
4

Quantification of Lumichrome and Riboflavin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lumichrome and riboflavin were analyzed by an HPLC apparatus (Shimadzu LC-20AP; Shimadzu, Kyoto, Japan) equipped with a Cosmosil 5C18MS-II column maintained at 50°C (2.0 by 150 mm; Nacalai Tesque, Kyoto, Japan) using 25% methanol in 10 mM acetate buffer, pH 4.5, at a flow rate of 0.4 ml/min. Lumichrome production was detected at 254 nm and confirmed by comparison of retention time with an authentic standard.
The 1H and 13C nuclear magnetic resonance (NMR) spectra of lumichrome were recorded on a Bruker Biospin Avance II 400 spectrometer (Brucher Biospin; Rheinstetten, Germany) in a pyridine-d5 solution. The 1H NMR chemical shift was referenced to residual C5HD4N (δ = 8.71, 7.55, 7.19) signals. The 13C NMR chemical shift was referenced to the solvent C5D5N (δ = 149.9, 135.5, 123.5).
+ Open protocol
+ Expand
5

RP-HPLC Quantification of HMF and Chlorogenic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
Determination of HMF and chlorogenic acid was performed using RP-HPLC (reversed phase-high performance liquid chromatographic method) method with UV detection, on Cosmosil 5C18-MS-II column (Nacalai Tesque, Inc., Kyoto, Japan), 150 mm long with an internal diameter of 4.6 mm. The analysis was performed with gradient elution with acetonitrile as phase A and 1% aqueous formic acid as phase B, at room temperature, with a flow rate of 1.0 mL/min, injection volume of 20 µL, and UV detection wavelength of 280 nm. Gradient conditions were: 0−9 min 5%−20% of A, 9−10 min holding 20% of A, 10−15 min 20%−5% of A, with an equilibration time of 10 min. The stock solutions of HMF and chlorogenic acid standard were prepared in a solvent and calibration was obtained at eight concentrations (concentration range 10.0, 20.0, 30.0, 50.0, 75.0, 100.0, 150.0, and 200.0 mg/L). Linearity of the HMF calibration curve was confirmed by R2 = 0.9996 with limit of detection (LOD) of 1.79 mg/mL, limit of quantification (LOQ) of 5.9 mg/mL, and HMF retention time of 10.7 min. Linearity of the chlorogenic acid calibration curve was confirmed by R2 = 0.9998 with limit of detection (LOD) of 0.016 mg/L, limit of quantification (LOQ) of 0.054 mg/L, and retention time of 14.3 min.
+ Open protocol
+ Expand
6

NMR, MS, and Apoptosis Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 1H-NMR (600 MHz) and 13C-NMR (150 MHz) spectra were measured in CDCl3 or DMSO-d6 using a JNM-ECZ600R spectrometer (JEOL, Tokyo, Japan) at room temperature, and the chemical shifts given as a δ (ppm) scale with tetramethylsilane (TMS) as the internal standard. The FAB-MS was measured using a JEOL JMS-HX110 mass spectrometer and acquired in a glycerol matrix. HPLC was conducted using a Waters machine equipped with a 1525 binary pump and a 2489 UV/Vis detector (Waters, Massachusetts, USA). Separation was carried out using a Cosmosil 5C18 MS-II column (20.0 mm × 250 mm, ODS, 5 µm; Nacalai Tesque, Kyoto, Japan). Apoptosis analyses were carried out using a Muse Cell Analyzer (Merck KGaA, Darmstadt, Germany).
+ Open protocol
+ Expand
7

Oligopeptide Separation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligopeptides were separated at 40 °C using a linear gradient of 0.1% formic acid (FA) in MS grade water (solvent A) and 0.1% FA in acetonitrile (ACN) (solvent B) for 20 min at a flow rate of 0.2 mL/min, and an Agilent 1200 series HPLC system (Agilent Technologies Inc., Santa Clara, CA, USA) equipped with a Cosmosil 5C18-MS-II column (Φ 2.0 mm × 150 mm, Nacalai Tesque Inc., Kyoto, Japan). The MS conditions comprised: drying gas, N2; flow rate, 8.0 L/min; drying gas temperature, 200 °C; drying gas pressure, 1.6 bar; HV capillary voltage, −4500 V; capillary exit, 70.0 V; skimmer 1, 50.0 V; hexapole 1, 23.0 V; hexapole RF, 100.0 Vpp; skimmer 2, 23.0 V; lens 1 transfer, 52.0 μs, and mass range m/z 100–1000. A calibration solution of 10 mM sodium formate in 50% ACN was injected at the beginning of each run. Data were analyzed using Bruker Data Analysis version 3.2 software (Bruker, Billerica, MA, USA). Calibration curves were prepared using 0.1–10 μM standards.
+ Open protocol
+ Expand
8

Synthesis and Characterization of STR-His16 Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
The STR-His16 peptide was purchased from Biologica Co. (Shanghai, China). His16 peptide was synthesized by solid-phase peptide synthesis, and STR-His16 peptide was prepared by treatment of the His16 peptide on resins with stearic acid (C17H35COOH) and diisopropylcarbodiimide in the presence of N-hydroxybenzotriazole. STR-His16 peptide with a stearyl moiety at the N-terminus and an amide group at the C-terminus was purified by high-performance liquid chromatography (HPLC) using a Waters 2489 UV/visible detector and 1524 binary pump (Waters, Milford, MA, USA) and a reversed phase COSMOSIL 5C18-MS-II column (10 mm × 250 mm; Nacalai Tesque, Kyoto, Japan) as previously described [4 (link)]. The column was run for 40 min at 3 mL/min with a linear gradient from 0% to 80% (v/v) acetonitrile in water containing 0.1% (v/v) trifluoroacetic acid. The purity of STR-His16 peptide was calculated from peak areas of HPLC chart, and final purity of the peptide was >95% (Figure S1A). The molecular masses were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (AutoFlex II; Bruker Daltonics, Billerica, MA, USA) (Figure S1B).
+ Open protocol
+ Expand
9

Synthesis and Characterization of Oxidized Lipid Isomers

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the preparation of PC 16:0/18:2;OOH and CE 18:2;OOH isomers, linoleic acid hydroperoxide (FA 18:2;OOH) isomers (FA 18:2(10E,12Z);9OOH, FA 18:2(10E,12E);9OOH, FA 18:2(8E,12Z);10OOH, FA 18:2(9Z,13E);12OOH, FA 18:2(9Z,11E);13OOH, and FA 18:2(9E,11E);13OOH) were firstly prepared following our previous report [5 (link),10 (link)]. The hydroperoxyl group of the resulting FA 18:2;OOH isomers was then protected with MxP for subsequent esterification [12 (link)]. Protected FA 18:2;OOH isomers were esterified with LPC 16:0/0:0 or cholesterol [12 (link),13 (link)]. Protected PC 16:0/18:2;OOH and CE 18:2;OOH isomers were finally deprotected and purified as in a previous study [12 (link),13 (link)].
The concentration of the standard of PC 16:0/18:2;OOH isomers was determined by quantifying inorganic phosphorus according to Bartlett method [14 (link)]. To determine the concentration of CE 18:2;OOH isomers, HPLC with chemiluminescence detection was used [1 (link)]. The separation was achieved using a COSMOSIL 5C18-MS-II column (5.0 µm, 4.6 × 250 mm, nacalai tesque, INC., Kyoto, Japan) with methanol/2-propanol (3:2, v/v) as the mobile phase (1 mL/min) at 40 °C. The concentration of CE 18:2;OOH isomers was calculated by using the standard of triacylglycerol hydroperoxide, whose concentration was known [15 (link)].
+ Open protocol
+ Expand
10

Iron-Dependent Metabolite Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
An overnight culture of Variovorax sp. H002 in 2xR2A liquid media was transferred to small baffled acrylic flasks containing 15 mL of freshly prepared modified M9 media fortified with 0, 0.5, 1, 5, 10, or 50 µM (final concentration) of FeCl3·6H2O. Upon cultivation at 30 °C/140 rpm for seven days, the cultures were centrifuged, and the supernatants were applied to pre-washed Sep-Pak C18 cartridges, which were then washed with water and eluted with methanol. The collected methanolic fractions were dried and resuspended in 0.5 mL of methanol. The particulate-free sample solutions (up to 100 µL) were injected into a Cosmosil 5C18-MS-II column (10 mm ID × 250 mm, Nacalai Tesque) attached to an HPLC with an autosampler, at a flow rate of 0.8 mL/min at 40 °C. Each analysis was performed using an aqueous acetonitrile mobile phase.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!